How to Help Your Patients Find Lumigan in Stock: A Provider's Guide

Ophthalmic medications like Lumigan (bimatoprost) are prescribed for lifelong conditions — meaning patients rely on consistent access for years or decades. When a patient calls your office because they can't fill their bimatoprost prescription, it creates an urgent interruption that puts their vision at risk and strains your practice's time. This guide provides a systematic approach to helping your patients find Lumigan in stock, reduce access friction, and protect their treatment continuity.

Why Lumigan Access Gaps Happen: A Clinical Summary

Lumigan is not in an FDA-declared shortage in 2026. The access difficulties your patients report stem from:

Individual pharmacy inventory gaps — community pharmacies stock limited units of brand Lumigan 0.01%

Brand-generic confusion — brand Lumigan 0.01% and generic bimatoprost 0.03% are not always interchangeable on a prescription without provider authorization

Insurance prior authorization hurdles — step therapy requirements delay approval for some commercial plans

Mail-order routing — plans that require specialty dispensing add 5–10 business days of processing time

Prescribing Practices That Reduce Access Friction

The following prescribing habits minimize the chance your patients will face a gap:

Allow generic substitution. Unless there is a specific clinical reason to require brand Lumigan, writing the prescription as "bimatoprost ophthalmic solution" or marking generic substitution permitted gives the pharmacist flexibility to use whichever formulation is in stock.

Prescribe 90-day supplies. A 90-day supply reduces how often patients must navigate refills and insurance hurdles. Most plans allow 90-day fills via mail order or preferred pharmacies.

Send prescriptions electronically. E-prescriptions reduce transcription errors and allow the pharmacy to immediately begin verifying insurance and stock. Ask your EHR system to flag bimatoprost for early refill reminders.

Document latanoprost step therapy up front. If you know the patient's plan requires step therapy, document latanoprost adequacy or failure in the chart at the time of prescribing. This speeds future PA approvals.

Prepare a bridge prescription. For patients in areas with known supply issues, proactively send a latanoprost bridge prescription they can fill if bimatoprost is unavailable. A brief note explaining the bridge use helps the pharmacy.

Referring Patients to medfinder for Pharmacy Search

When patients call your office reporting that their local pharmacy is out of Lumigan, refer them to medfinder. medfinder calls pharmacies near the patient's location to check actual inventory, then texts the patient which pharmacies have their medication in stock. This removes the burden from your front desk staff and gets the patient actionable information faster.

Consider adding medfinder to your practice's patient education materials or discharge instructions for patients on bimatoprost, latanoprost, or any other specialty eye drop.

Script for Communicating Access Issues to Patients

When educating patients at their visit about potential access difficulties, consider using language like:

"Your Lumigan eye drops are critically important for protecting your vision. If your pharmacy ever tells you they don't have it in stock, don't just wait — call us, and also use a service called medfinder that can help you find a pharmacy nearby that has it. Never skip your drops for more than one or two days without calling us first."

Handling Inbound Access Calls at Your Practice

Create a standard response protocol for staff when patients call about bimatoprost access issues:

Ask the patient if they've tried generic bimatoprost 0.03% — many pharmacies that don't have brand Lumigan have the generic.

Direct them to medfinder.com to search nearby pharmacies.

If the patient cannot locate stock within 24 hours, have the provider issue a latanoprost bridge prescription.

For high-risk patients (advanced glaucoma, single-eye vision), escalate to the provider same day.

Cost Assistance Options to Share With Patients

Some patients avoid filling Lumigan due to cost, not supply. Remind your team to discuss:

AbbVie At Your Service co-pay card: Up to $2,640/year for commercially insured patients; savewithays.com

myAbbVie Assist: Free medication for uninsured/underinsured patients who qualify; abbvie.com

GoodRx: Generic bimatoprost as low as $18–$78 at participating pharmacies

For more clinical context, see: Lumigan shortage: What providers and prescribers need to know in 2026.